Clinical Research

Raja Narayanan, Director, Clinical Research
Contact: 040-3061 2618
Mail: narayanan@lvpei.org


Kallam Anji Reddy Campus
Manager Operations: T. Charitha
Study Co-ordinators: Deepthi, Ravi Teja, Kranthi Kumar, Esankara Raju, Aseema, Soundharya
Study Optometrists: Mr. Abhilash Goud, M. Liviza
Senior Clinical Data Analyst : E. Shobha Laxmi
Data Entry Operator: V. Vijaya Laxmi.

Contact Number: 040-3061 2209/2205


Bhubaneswar Campus
Clinical Research Coordinators: Debashish Das, Mohammed Hasibur Rahman
Study Optometrists: Mr.Krushna Gopal Panda, Mr. Aniruddha Banerjee.


Optometrists Involved In Research
Optometrists Involved In Research

KAR Campus
S.No Name of the Project Principal Investigator Collaborator Duration
1. A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study Assessing the Safety and Efficacy of Intravitreal Injections of DE-109 (three doses) for the Treatment of active, Non-Infectious Uveitis of the Posterior Segment of the eye. Dr Somasheila Murthy Excel Life Sciences 2011 - 2016
2. A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye. Dr Mudit Tyagi Excel Life Sciences 2012 - 2017
3. Clinical Efficacy of Intravitreal administration of Bevacizumab Combined with navigated Laser treatment in patients with Clinically Significant Macular Edema(CSME) Dr Jay Chabblani OD- OS 2012- 2016
4. A prospective, single centre, open label, feasibility clinical evaluation of Epivision microkeratome with Nanotome head in correcting refractive errors II Dr Pravin Krishna Gebauer 2014 – 2016
5. A prospective contra lateral lens wear randomised controlled 3 months clinical trial to test the efficacy and safety of surface modified contact lens during continous wear modality Dr Pravin Krishna UNSW 2015-2016
6. An observational muti-center, open, study assessing the efficacy and safety of Ranibizumab intravitreal injections (IVI) of in patients with visual impairment due to Macular edema secondary to retinal vein occlusion(RVO) Dr Raja Narayanan Novartis 2016-2017
7. A multi center,open label, observational study to evaluate the efficacy and safety of intravitreal injections (IVI)of Ranibizumab in patients with visual impairment due to Diabetic Macular Edema (DME) Dr Padmaja Kumari Novartis 2016-2017
8. Retinopathy of Prematurity (ROP) Dr. Subhadra Jalali Public Health foundation 2016-2017
9. A Phase 2/3, Randomized , Double Masked, Sham Controlled trial of QPI-1007 delivered by single or multi dose intravitreal injection(s) to subjects with acute non arteritic anterior Ischemic optic neuropathy (NAION) Dr. Ramesha Kekunnaya Quark Pharmaceuticals, Inc. 2016-2017
10. A Prospective, Multicenter clinical study to assess safety,Immunogenicity and Efficacy of Ranibizumab (Intas Pharmaceutical Limited) for the treatment of treatment of Wet AMD(Age Related macular Degeneration) Dr. Vivek Dave Intas Pharmaceutical Limited 2017-2018
11. An Observational, prospective,post marketing surveillance program to evaluate the safety profile of Intravitreal Ozurdex® in the treatment of visual impairment due to diabetic macular edema by actively identifying and evaluating the occurrence of adverse events and serious adverse events information. Dr. Divya Balakrishnan Clintec International 2017-2018
12. A Phase 3, RandomizEd, MAsked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for tHe TReatment of Subjects with Macular Edema associated with Non-Infectious UvEitis. Dr. Mudit Tyagi Excel Life Sciences 2017-2018

GMRV Campus
S.No Name of the Project Principal Investigator Supported by Duration
1. External Revision of Failed Primary External Dacryocystorhinostomy: A retrospective analysis of the causes of failure and outcomes of revision surgery at tertiary eye care centre Samir Mahapatra In-House 18-Mar-15
2. Hydroxy Chloroquine (HCQ) Retinal Toxicity:Necessity for screening in SouthIndian Population Abhishek C Bawdekar In-House 01-Apr-15
3. Co-relatives of varoins serum diomarkers with severits of diabetic retinopathu in diabetes patients Dr.Annapurna In-House 01-Jul-15
4. Amblyopia in Accommodative Esotropias: Incidence, Characteristics, and outcomes in a south Indian Population. Dr Virender Sachdeva In-House 01-Jul-16
5. Clinical Efficacy of Intravitreal administration of Bevacizumab Combined with navigated Laser treatment in patients with Clinically Significant Macular Edema(CSME) Dr Virender Sachdeva In-House 01-Jul-16
6. Efficacy and Adverse responses of Atropine penalization as primary treatment modality for unilateral amblyopia: experience from a tertiary eye care centre in South India Dr Virender Sachdeva In-House 01-Jul-16

Bhubaneswar Campus
S.No Name of the Project Principal Investigator Supported by Duration
1. A Phase III,Multinational,Multicenter, Randomized,Double-Masked,Study Assessing  the Safety and Efficacy of Intravitreal Injections of  DE-109(three doses) for the Treatment of active, Non-Infectious Uveitis of the eye Soumyava Basu Santen Incorporated Santen Incorporated
2. Biomarkers of Diabetic Retinopathy Progression(C-Tracer) Rajeev Reddy, Co-I:
Tapas Ranjan Padhy,
Soumayava Basu,
Umesh Chandra Behera
Champalimaud Foundation (Grant) 2013 - 2017
3. LUMINOUS:Study to observe the effectiveness and safety of LUCENTIS® through individualized patient treatment and associated outcomes Taraprasad Das Novartis 2012 - 2017
4. A Multicentre,Randomized,Double-Masked,3 Parallel Arms, Placebo Controlled Study to Assess the efficacy and Safety  of NOVA22007 1MG/ML(Ciclosporin/Cyclosporine) Eye drops,EmulsionAdministered in Paediatric patients with active severe Vernal Keratoconjunctivitis with Severe Keratitis. Srikant Kumar Sahu Novagali Pharma 2014 - 2016
5. Clinical Efficacy of Intravitreal administration of Bevacizumab Combined with navigated Laser treatment in patients with Clinically Significant Macular Edema(CSME) Umesh Chandra
Behera
Novartis 2014 - 2016
6. A 12-month, phase III, randomized, double-masked, multicenter, active- controlled study to evaluate the efficacy and safety of two individualized regimens of 0.5 mg ranibizumab vs. verteporfin PDT in patients with visual impairment due to choroidal neovascularization secondary to pathologic myopia (Brilliance) Umesh Chandra
Behera
Novartis 2014 - 2016
7. A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye. Soumayava Basu PSivida Corp 2015 – 2018
8. A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the   Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects with Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program (Spring Study) Extension of SAKURA. SANTEN INCORPORATED Dr Soumyava basu 2015 Onwards
TOP